Cargando…

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients

Detalles Bibliográficos
Autores principales: Tsai, Ming-Ju, Wu, Ping-Hsun, Sheu, Chau-Chyun, Hsu, Ya-Ling, Chang, Wei-An, Hung, Jen-Yu, Yang, Chih-Jen, Yang, Yi-Hsin, Kuo, Po-Lin, Huang, Ming-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864416/
https://www.ncbi.nlm.nih.gov/pubmed/27169795
http://dx.doi.org/10.1038/srep25880
_version_ 1782431624632205312
author Tsai, Ming-Ju
Wu, Ping-Hsun
Sheu, Chau-Chyun
Hsu, Ya-Ling
Chang, Wei-An
Hung, Jen-Yu
Yang, Chih-Jen
Yang, Yi-Hsin
Kuo, Po-Lin
Huang, Ming-Shyan
author_facet Tsai, Ming-Ju
Wu, Ping-Hsun
Sheu, Chau-Chyun
Hsu, Ya-Ling
Chang, Wei-An
Hung, Jen-Yu
Yang, Chih-Jen
Yang, Yi-Hsin
Kuo, Po-Lin
Huang, Ming-Shyan
author_sort Tsai, Ming-Ju
collection PubMed
description
format Online
Article
Text
id pubmed-4864416
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48644162016-05-23 Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients Tsai, Ming-Ju Wu, Ping-Hsun Sheu, Chau-Chyun Hsu, Ya-Ling Chang, Wei-An Hung, Jen-Yu Yang, Chih-Jen Yang, Yi-Hsin Kuo, Po-Lin Huang, Ming-Shyan Sci Rep Corrigenda Nature Publishing Group 2016-05-12 /pmc/articles/PMC4864416/ /pubmed/27169795 http://dx.doi.org/10.1038/srep25880 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Corrigenda
Tsai, Ming-Ju
Wu, Ping-Hsun
Sheu, Chau-Chyun
Hsu, Ya-Ling
Chang, Wei-An
Hung, Jen-Yu
Yang, Chih-Jen
Yang, Yi-Hsin
Kuo, Po-Lin
Huang, Ming-Shyan
Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
title Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
title_full Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
title_fullStr Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
title_full_unstemmed Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
title_short Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
title_sort corrigendum: cysteinyl leukotriene receptor antagonists decrease cancer risk in asthma patients
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864416/
https://www.ncbi.nlm.nih.gov/pubmed/27169795
http://dx.doi.org/10.1038/srep25880
work_keys_str_mv AT tsaimingju corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT wupinghsun corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT sheuchauchyun corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT hsuyaling corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT changweian corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT hungjenyu corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT yangchihjen corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT yangyihsin corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT kuopolin corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients
AT huangmingshyan corrigendumcysteinylleukotrienereceptorantagonistsdecreasecancerriskinasthmapatients